Murray CJ, Ikuta KS, Sharara F, Swetschinski L, Robles Aguilar G, Gray A, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399:629–55.
Tackling drug-resistant. infections globally: final report and recommendations. https://www.cabidigitallibrary.org/doi/full/10.5555/20173071720. Accessed 21 Aug 2024.
WHO publishes list of bacteria for which new antibiotics are urgently needed. https://www.who.int/news/item/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed. Accessed 21 Aug 2024.
Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO. Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis. 2001;32:1162–71.
Article CAS PubMed Google Scholar
Tumbarello M, Spanu T, Sanguinetti M, Citton R, Montuori E, Leone F, et al. Bloodstream infections caused by extended-Spectrum-β-Lactamase-producing Klebsiella pneumoniae: risk factors, Molecular Epidemiology, and clinical outcome. Antimicrob Agents Chemother. 2006;50:498–504.
Article CAS PubMed PubMed Central Google Scholar
Rottier WC, Ammerlaan HSM, Bonten MJM. Effects of confounders and intermediates on the association of bacteraemia caused by extended-spectrum β-lactamase-producing Enterobacteriaceae and patient outcome: a meta-analysis. J Antimicrob Chemother. 2012;67:1311–20.
Article CAS PubMed Google Scholar
Paterson DL, Bonomo RA. Extended-spectrum β-lactamases: a clinical update. Clin Microbiol Rev. 2005;18:657–86.
Article CAS PubMed PubMed Central Google Scholar
Bush K, Bradford PA. Epidemiology of β-lactamase-producing pathogens. Clin Microbiol Rev. 2020;33.
Castanheira M, Simner PJ, Bradford PA. Extended-spectrum β-lactamases: an update on their characteristics, epidemiology and detection. JAC-Antimicrobial Resist. 2021;3.
Abrar S, Hussain S, Khan RA, Ul Ain N, Haider H, Riaz S. Prevalence of extended-spectrum-β-lactamase-producing Enterobacteriaceae: first systematic meta-analysis report from Pakistan. Antimicrob Resist Infect Control. 2018;7:1–11.
Diriba K, Awulachew E, Gemede A, Anja A. The magnitude of extended-spectrum beta-lactamase- producing Enterobacteriaceae from clinical samples in Ethiopia: a systematic review and meta-analysis. Access Microbiol. 2021;3:000195.
Article CAS PubMed PubMed Central Google Scholar
Musa BM, Imam H, Lendel A, Abdulkadir I, Gumi HS, Aliyu MH, et al. The burden of extended-spectrum β-lactamase-producing Enterobacteriaceae in Nigeria: a systematic review and meta-analysis. Trans R Soc Trop Med Hyg. 2020;114:241–8.
Article CAS PubMed Google Scholar
Khadka C, Shyaula M, Syangtan G, Bista S, Tuladhar R, Singh A, et al. Extended-spectrum β-lactamases producing Enterobacteriaceae (ESBL-PE) prevalence in Nepal: a systematic review and meta-analysis. Sci Total Environ. 2023;901:166164.
Article CAS PubMed Google Scholar
Sonda T, Kumburu H, van Zwetselaar M, Alifrangis M, Lund O, Kibiki G, et al. Meta-analysis of proportion estimates of extended-spectrum-Beta-lactamase-producing Enterobacteriaceae in East Africa hospitals. Antimicrob Resist Infect Control. 2016;5:1–9.
Zhou X, García-Cobos, S, Ruijs, GJHM, Kampinga, GA, Arends, JP, Borst, DM, et al. Epidemiology of extended-spectrum β-lactamase-producing E. Coli and Vancomycin-resistant enterococci in the Northern Dutch-German cross-border region. Front Microbiol. 2017;8(OCT):275734.
Enoch DA, Brown F, Sismey AW, Mlangeni DA, Curran MD, Karas JA, et al. Epidemiology of extended-spectrum beta-lactamase-producing Enterobacteriaceae in a UK district hospital; an observational study. J Hosp Infect. 2012;81:270–7.
Article CAS PubMed Google Scholar
Australian Passive AMR Surveillance (APAS) | Australian Commission on Safety and Quality in Health Care. https://www.safetyandquality.gov.au/our-work/antimicrobial-resistance/antimicrobial-use-and-resistance-australia-aura/hospital-and-community-antimicrobial-resistance/australian-passive-amr-surveillance-apas. Accessed 6 Nov 2024.
Husna A, Rahman MM, Badruzzaman ATM, Sikder MH, Islam MR, Rahman MT, et al. Extended-spectrum β-Lactamases (ESBL): challenges and opportunities. Biomedicines. 2023;11:2937.
Article CAS PubMed PubMed Central Google Scholar
Ayukekbong JA, Ntemgwa M, Atabe AN. The threat of antimicrobial resistance in developing countries: causes and control strategies. Antimicrob Resist Infect Control. 2017;6:1–8.
Zeid W, Hamed M, Mansour N, Diab R. Prevalence and associated risk factors of self-medication among patients attending El-Mahsama family practice center, Ismailia, Egypt. Bull Natl Res Cent 2020 441. 2020;44:1–5.
Elden NMK, Nasser HA, Alli A, Mahmoud N, Shawky MA, Ibrahim AAEA, et al. Risk factors of Antibiotics Self-medication practices among University students in Cairo, Egypt. Open Access Maced J Med Sci. 2020;8 E:7–12.
Abdelaziz AI, Tawfik AG, Rabie KA, Omran M, Hussein M, Abou-Ali A, et al. Quality of community pharmacy practice in antibiotic self-medication encounters: a simulated patient study in upper Egypt. Antibiotics. 2019;8:35.
Article PubMed PubMed Central Google Scholar
Hamdy NA, Kandil NH, Amer AN. Status of antimicrobial stewardship implementation in selected Egyptian hospitals: a cross-sectional study. Egypt J Med Microbiol. 2022;31:77–83.
Salem MR, Youssef MRL. Health care providers’ perspectives for providing quality infection control measures at the neonatal intensive care unit, Cairo University Hospital. Am J Infect Control. 2017;45:e99–102.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372.
The burden of health care-associated infection worldwide. https://www.who.int/news-room/feature-stories/detail/the-burden-of-health-care-associated-infection-worldwide. Accessed 9 Nov 2024.
Sikora A, Zahra F. Nosocomial Infections. StatPearls. 2023.
Greenwood D, Barer MR, Slack RCB, Irving WL. Medical Microbiology: Eighteenth Edition. Elsevier Inc.; 2012.
JBI. JBI Critical Appraisal Tools | JBI. 2020;:1–5. https://jbi.global/critical-appraisal-tools. Accessed 25 Aug 2024.
9.5. 2 Identifying and measuring heterogeneity. https://handbook-5-1.cochrane.org/chapter_9/9_5_2_identifying_and_measuring_heterogeneity.htm. Accessed 22 Aug 2024.
Essam E, Mohamed EI, Ali E-MS, Farg AY, Mohamed Elkady I, Ali El-Masry S, et al. Extended-spectrum β-lactamase producing Escherichia coli and Klebsiella pneumoniae in urinary tract infections. Egypt J Exp Biol. 2011;7:135–41.
Abd El-hamid N, Mohamed M, Allam A. Nosocomial infections with extended Spectrum Beta Lactamase Producing Enterobacteriaceae in Pediatric Intensive. Egypt J Med Microbiol. 2010;19:263–72.
Rizk MA, Zaki MES, Mohamed HAA, Abdel-Hady DM, Montasser K. Extended-spectrum β-Lactamase-producing Escherichia coli and Virulence genes in Pediatric patients with Health Care-Associated urinary tract infections. Infect Disord - Drug Targets. 2022;23.
ElTaweel M, Said HS, Barwa R. Emergence of extensive drug resistance and high prevalence of multidrug resistance among clinical Proteus mirabilis isolates in Egypt. Ann Clin Microbiol Antimicrob. 2024;23:1–11.
Thabit AG, El-Khamissy TR, Ibrahim MA, Attia AE. Detection of extended-spectrum β-lactamase enzymes (ESBLs) produced by Escherichia coli urinary pathogens at Assiut University Hospital. Bull Pharm Sci Assiut Univ. 2011;34:93–103.
El Maghraby HM, El-sayed HA, Hussein S, El Azawy DS, Attia O, Orabi EE, et al. Detection of phylogrouping, adhesin, and extended spectrum β-lactamases genes in hospital acquired uropathogenic Escherichia coli isolates. Mol Biol Rep. 2024;51:1–9.
Essawy SH, Ramadan MO, Maseehah MS, Ghalwash MAEE. Detection of Extended Spectrum Beta-lactamase Producing Escherichia coli among Community-acquired and hospital-acquired urinary tract infections in Tanta University Hospital. Egypt J Med Microbiol. 2018;27:99–105.
Gaballah A, Ali GH, Emad R, Omar H, Abou-Shleib HM. Beta-lactam Resistance Profile among Klebsiella pneumoniae clinical isolates from Alexandria, Egypt. Curr Microbiol. 2023;80:1–14.
Ragab RN, El-Marakby HAF, Khalil AE, Nassar NM, Habashy OY, Shaker DA. Phenotypic and genotypic detection of extended spectrum beta lactamase producing Escherichia coli in urinary tract infection of pregnant women in Benha. Egypt J Med Microbiol. 2024;33:95–102.
Masoud SM, El-Baky RMA, Aly SA, Ibrahem RA. Prevalence of multidrug resistant Escherichia coli recovered from patients suffering from urinary tract infections. Nov Res Microbiol J. 2022;6:1543–56.
El Kholy AA, Gomma HE, Younan MA, Thabet EH, Haleim MMA, El Anany MG, et al. Extended spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli strains in a pediatric teaching hospital in Egypt. Med Res J. 2011;10:27–31.
Rashwan RS, Galal SM, Abd El-Kareem DM, Ghandour AMA, Abd El-Hamid RF. Extended-spectrum beta-lactamase genes among Gram negative bacilli isolates from Egyptian children with diarrhea. Microbes Infect Dis. 2023;4:1312–24.
El-Mahdy TS, Abdelaziz MO, El-Domany RA. Prevalence and molecular characterization of extended spectrum β-lactamases in Klebsiella pneumoniae isolates from cancer patients and others. Int J Pharm Pharm Sci. 2015;7:122–7.
Khalifa SM, Abd El-Aziz AM, Hassan R, Abdelmegeed ES. β-lactam resistance associated with β-lactamase production and porin alteration in clinical isolates of E. Coli and K. pneumoniae. PLoS ONE. 2021;16:e0251594.
Article CAS PubMed PubMed Central Google Scholar
Elsayed AGA, Badr DF, El Kheir NYA, Zaki MES, Mossad AEM, Mahmoud EMF. Prevalence of extended-spectrum beta-lactamase and molecular detection of blaTEM, blaSHV, and blaCTX-M genotypes among gram-negative Bacilli isolates from hospital acquired infections in pediatrics, one institutional study. Ital J Pediatr. 2024;50:1–8.
Comments (0)